Published on 25/12/2025
How to Avoid Common Errors in Adverse Event Reporting During Clinical Trials
Adverse Event (AE) reporting is an essential aspect of clinical trial oversight. Yet, even experienced professionals often make avoidable errors that can compromise patient safety, delay regulatory submissions, or result in findings during audits. Understanding common mistakes and implementing preventive strategies ensures compliance with EMA, CDSCO, and other regulatory authorities. This guide outlines the most frequent AE reporting errors and how to mitigate them effectively.
Why AE Reporting Accuracy Matters:
- Protects trial subjects by ensuring swift response to safety issues
- Supports accurate safety signal detection
- Prevents regulatory non-compliance and trial holds
- Enables proper evaluation of investigational product risks
- Facilitates data integrity in sponsor submissions
Top 10 Common AE Reporting Errors:
1. Delayed Reporting of SAEs
One of the most frequent and serious issues is the failure to report Serious Adverse Events (SAEs) within the required timeframe (usually within 24 hours to the sponsor).
How to Avoid: Train site staff on timelines and set automatic alerts in EDC systems.
2. Misclassification of Severity vs. Seriousness
Severity relates to the intensity of an AE, while seriousness relates to the outcome. Confusing the two can lead
How to Avoid: Use a decision support tool or flowchart and review GMP SOP documentation to clarify criteria.
3. Missing Source Documentation
AEs reported in the CRF/EDC but not found in the source documents raise audit red flags.
How to Avoid: Ensure all AEs are recorded contemporaneously in EMR or site notes.
4. Incomplete AE Details
Key elements such as onset date, resolution date, causality, or action taken are often omitted.
How to Avoid: Use a checklist to verify AE completeness before finalizing reports.
5. Failure to Reconcile AE Data
Differences between AE logs, safety databases, and site files lead to inconsistencies.
How to Avoid: Perform monthly reconciliation using tools from Pharma SOP templates.
6. Incorrect Attribution of Causality
Over- or under-reporting causality can distort safety profiles and affect trial conclusions.
How to Avoid: Train investigators in objective causality assessments using standard algorithms like WHO-UMC or Naranjo.
7. Reporting Non-Protocol AEs
Some AEs, such as pre-existing conditions or unrelated events, are mistakenly reported.
How to Avoid: Understand protocol-specific reporting thresholds and exclusions.
8. Ignoring Follow-Up Reports
Initial AE report is filed, but updates on resolution, hospitalization, or outcome are missing.
How to Avoid: Track pending AE follow-ups and link outcomes clearly.
9. Inconsistent Terminology
Using vague or non-medical language (“unwell”, “tired”) can hinder interpretation.
How to Avoid: Use MedDRA terminology and approved AE dictionaries.
10. Lack of IRB Notification
Investigators may neglect to inform Institutional Review Boards (IRBs) of SAEs or unanticipated problems.
How to Avoid: Maintain a reporting calendar for sponsor and IRB timelines.
Audit Findings and Real Examples:
- “AE reported to sponsor but missing in site source notes.”
- “SAE reported late by 5 days due to unclear delegation.”
- “Causality not documented; resolved event logged as ongoing.”
- “Discrepancy in SAE description across forms.”
To avoid these issues, cross-verify all entries across the Trial Master File, EDC, and safety databases regularly.
Checklist for Error-Free AE Reporting:
- [ ] AE is promptly identified and recorded
- [ ] Complete information logged (dates, description, severity, seriousness)
- [ ] Causality assessed and noted
- [ ] SAE reported within 24 hours
- [ ] AE entered in EDC matches source notes
- [ ] Follow-up reports submitted on time
- [ ] Reconciliation performed monthly
- [ ] IRB informed (if applicable)
- [ ] All documentation filed in TMF
Tools to Support AE Compliance:
- Electronic alerts for due dates
- Pre-built AE templates from StabilityStudies.in
- Integrated safety reporting dashboards
- AE classification quick-reference cards
Best Practices for Continuous Improvement:
- Conduct AE reporting refresher training quarterly
- Perform internal audits of AE logs every 2 months
- Review regulatory updates from CDSCO and international agencies
- Update SOPs in response to inspection findings
Conclusion:
Adverse event reporting errors are often preventable with clear SOPs, training, and vigilant data review. By understanding the most common mistakes and implementing systematic controls, clinical trial teams can improve safety outcomes, meet regulatory expectations, and strengthen the credibility of their research. Make AE compliance a team responsibility to build audit-ready, patient-centric studies.